MAPKAPK2 and neuroblastoma: In summary, our studies define the MK2/OCT4/c-MYC axis as a novel mechanism of MYC transcriptional activation in neuroblastoma that mediates resistance to 13-cisRA by rescuing 13-cisRA induced MYCN downregulation and is commonly found in progressive disease neuroblastomas.